Although alterations in xenobiotic metabolism are considered causal in the development of
bladder cancer, the precise mechanisms involved are poorly understood. In this study, we …

PURPOSE: The current use of cystoscopy for screening and detecting bladder cancer is
invasive and expansive. Various urine based biomarkers have been used for this purpose …

Introduction: Metabolomics is a chemical process, involving the characterization of
metabolites and cellular metabolism. Recent studies indicate that numerous metabolic …

Metabolomic analysis has proven to be a useful tool in biomarker discovery and the
molecular classification of cancers. In order to find new biomarkers, and to better understand …

Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of
recurrence after initial diagnosis and treatment. As a result, recurrent surveillance, primarily …

Bladder cancer (BC) is a common cancer but diagnostic modalities, such as cystoscopy and
urinary cytology, have limitations. Here, high-performance liquid chromatography …

Urine metabolomics have been used to identify biomarkers for clinical diseases. However,
inter‐individual variations and effect factors need to be further evaluated. In our study, we …

Metabolism reprogramming is considered a hallmark of cancer. The study of bladder cancer
(BC) metabolism could be the key to developing new strategies for diagnosis and therapy …

Urothelial carcinoma is the most common form of bladder cancer, but pathway changes that
occur with stage‐wise progression have not been well defined. We used a metabolomics …

Metabolomics has recently proved to be useful in the area of biomarker discovery for
cancers in which early diagnostic and prognostic biomarkers are urgently needed, as is the …